ESSA Pharma to Present at Upcoming September Investor Conferences
ESSA Pharma Inc. (NASDAQ: EPIX), a clinical-stage pharmaceutical company dedicated to prostate cancer treatments, announces that CEO David R. Parkinson will present at two upcoming virtual investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ESSA Pharma Inc. (NASDAQ: EPIX), a clinical-stage pharmaceutical company dedicated to prostate cancer treatments, announces that CEO David R. Parkinson will present at two upcoming virtual investor conferences. Key details include the H.C. Wainwright Annual Global Investment Conference on September 13, 2021, and the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 21, 2021. Investors can access webcasts on ESSA's website, with archives available for 90 days post-event.
Details
News Market Reaction – EPIX
The recorded move for EPIX in the trading session of this news was +2.22%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
VANCOUVER, Canada and HOUSTON, Texas, Aug. 31, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that David R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at two upcoming virtual investor conferences. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be available for one-on-one meetings.
Presentation Details
Event: H.C. Wainwright Annual Global Investment Conference
Date: Monday, September 13, 2021
Time (on-demand): 7:00 a.m. ET
Event: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date: Tuesday, September 21, 2021
Time: 9:05 a.m. ET
Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the events, the webcasts will be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.
View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-upcoming-september-investor-conferences-301366567.html
SOURCE ESSA Pharma Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.